In this study, the authors aim to comprehensively profile the expression of CUL3 and key regulatory molecules, including NRF2, NF-κB, miRNA-146a, and Foxp3, in patients with vitiligo, integrating clinical, in silico docking, and bioinformatics analyses. This evidence concerns the gene NFE2L2 and vitiligo.